MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Meropenem And Sodium Chloride In Duplex Container, and what generic alternatives are available?
Meropenem And Sodium Chloride In Duplex Container is a drug marketed by B Braun Medical Inc and is included in one NDA.
The generic ingredient in MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER is meropenem. There are thirty-two drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the meropenem profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Meropenem And Sodium Chloride In Duplex Container
A generic version of MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER was approved as meropenem by ACS DOBFAR on October 26th, 2011.
Summary for MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 84 |
Patent Applications: | 5,579 |
Formulation / Manufacturing: | see details |
DailyMed Link: | MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER at DailyMed |
Pharmacology for MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER
Drug Class | Penem Antibacterial |
Anatomical Therapeutic Chemical (ATC) Classes for MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER
US Patents and Regulatory Information for MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B Braun Medical Inc | MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER | meropenem | POWDER;INTRAVENOUS | 202106-002 | Apr 30, 2015 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
B Braun Medical Inc | MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER | meropenem | POWDER;INTRAVENOUS | 202106-001 | Apr 30, 2015 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |